|Bid||0.00 x 0|
|Ask||0.00 x 0|
|Day's range||96.11 - 98.94|
|52-week range||78.26 - 111.57|
|Beta (5Y monthly)||0.33|
|PE ratio (TTM)||60.10|
|Forward dividend & yield||1.24 (1.43%)|
|Ex-dividend date||18 Aug 2022|
|1y target est||N/A|
Diagnostics and pharmaceutical services technologies investor Conviction Life has filed for an initial public offering to trade on the main market of the London Stock Exchange, the company said on Friday. Conviction Life is targeting gross proceeds of up to 100 million pounds ($121 million) through the issue of up to 100 million ordinary shares. The company will also undertake a placing programme for up to 250 million ordinary shares and plans to start trading on Dec. 16.
These three stocks are easily beating the FTSE 100 this year. They look poised to continue outperforming well into the new year too. The post 3 stocks set to crush the FTSE 100 (again) in 2023 appeared first on The Motley Fool UK.
There are two stocks I will never sell. Both British brands remain at the cutting edge of long-term trends like no others I have come across. The post 1,000%+ over the past decade! 2 stocks I will never sell appeared first on The Motley Fool UK.